Bruker Corporation Stock

$29.54

0.65% today

Nasdaq, Sep 04, 04:17 pm CET

ISIN

US1167941087

Symbol

BRKR

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P MidCap 400

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Overview Dividends Analysts Charts News Strategies

Bruker Corporation Stock price

$29.35

-11.28 27.76% 5Y

Nasdaq, Closing price Wed, Sep 03 2025

-3.88 11.68%

ISIN

US1167941087

Symbol

BRKR

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P MidCap 400

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Key metrics

Basic

Market capitalization

$4.5b

Enterprise Value

$6.8b

Net debt

$2.3b

Cash

$92.0m

Shares outstanding

151.7m

Valuation (TTM | estimate)

P/E

56.4 | 14.3

P/S

1.3 | 1.3

EV/Sales

2.0 | 1.9

EV/FCF

137.9

P/B

2.5

Dividends

DPS

$0.20

Yield 1Y | 5Y

0.7% | 0.3%

Growth 1Y | 5Y

0.0% | 4.6%

Payout 1Y | 3Y

26.3% | 10.6%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$3.4b | $3.5b

EBITDA

$544.0m | $623.3m

EBIT

$333.6m | $463.4m

Net Income

$79.6m | $311.4m

Free Cash Flow

$49.3m

Growth (TTM | estimate)

Revenue

10.4% | 4.6%

EBITDA

-3.9% | 9.2%

EBIT

-20.9% | 19.7%

Net Income

-77.4% | 175.3%

Free Cash Flow

-70.7%

Financial Health

Equity Ratio

30.7%

Return on Equity

6.4%

ROCE

6.7%

ROIC

3.7%

Debt/Equity

1.3

EPS

$0.5

FCF per Share

$0.3

Short interest

9.5%

Employees

11k

Rev per Employee

$300.0k

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Get Started for Free Today

Bruker Corporation Stock Analysis

Unlock Scores for Free

??

21 Analysts have issued a Bruker Corporation forecast:

12x Buy

57%

8x Hold

38%

More details on Analyst Estimates Including Price Targets

21 Analysts have issued a Bruker Corporation forecast:

Buy

57%

Hold

38%

Sell

Analyst Estimates with Stock Price Targets

Financial data from Bruker Corporation

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	3,443 3,443	10% 10% 100%
- Direct Costs	1,772 1,772	14% 14% 51%
Gross Profit	1,671 1,671	7% 7% 49%
- Selling and Administrative Expenses	934 934	16% 16% 27%
- Research and Development Expense	400 400	22% 22% 12%
EBITDA	544 544	4% 4% 16%
- Depreciation and Amortization	210 210	46% 46% 6%
EBIT (Operating Income) EBIT	334 334	21% 21% 10%
Net Profit	80 80	77% 77% 2%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Bruker Corporation Stock News

Negative

The Motley Fool

●

about 3 hours ago

Why Bruker Stock Tumbled by Almost 12% Wednesday

Medical device and diagnostics company Bruker (BRKR -11.68%) wasn't looking like the cure for any investor's ailments on Wednesday. The stock was hit with an assertive sell-off from the market, leaving it with a nearly 12% price decline on the session.

Neutral

Business Wire

●

about 11 hours ago

Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced the pricing of its previously announced public offering of $600.0 million of 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock”). Bruker has granted the underwriters a 30-day option to purchase up to an additi...

Neutral

Business Wire

●

2 days ago

Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced it has commenced a public offering, subject to market and other conditions, of $600.0 million of Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock”). Bruker expects to grant the underwriters a 30-day option to purcha...

More Bruker Corporation News

Company Profile

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.

Head office	United States
CEO	Frank Laukien
Employees	11,396
Founded	1960
Website	www.bruker.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now